Cargando…

Physical Activity in Adults with Cystic Fibrosis Receiving Intravenous Antibiotics in Hospital and in the Community§

INTRODUCTION : Intravenous antibiotic therapy (IVAT) for CF acute pulmonary exacerbations (APE) can be delivered in hospital or in the community. This study aimed to compare physical activity in CF patients receiving hospital and community-delivered IVAT, as well as other health outcomes. MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khiroya, Heena, Pound, Rebecca, Qureshi, Ushna, Brown, Catherine, Barrett, Joanne, Rashid, Rifat, Whitehouse, Joanna L, Turner, Alice M, Nash, Edward F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347052/ https://www.ncbi.nlm.nih.gov/pubmed/25741394 http://dx.doi.org/10.2174/1874306401509010015

Ejemplares similares

Improving the care of patients with cystic fibrosis (CF)
por: Khan, Ahsan Aftab, et al.
Publicado: (2017)

The role of iron in pulmonary pathology
por: Khiroya, Heena, et al.
Publicado: (2015)

Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes
por: Kempegowda, Punith, et al.
Publicado: (2020)

Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis — Is it good for the patient?
por: Sequeiros, Iara Maria, et al.
Publicado: (2009)

A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis
por: Nash, Edward F., et al.
Publicado: (2022)

A prospective pilot study of home monitoring in adults with cystic fibrosis (HOME-CF): protocol for a randomised controlled trial
por: Choyce, Jocelyn, et al.
Publicado: (2017)

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis
por: Deschamp, Ashley R, et al.
Publicado: (2017)

Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
por: Hewer, Simon C Langton, et al.
Publicado: (2020)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
por: Barr, Helen L., et al.
Publicado: (2015)

Weight gain during acute treatment of an initial pulmonary exacerbation is associated with a longer interval to the next exacerbation in adults with cystic fibrosis
por: Barr, Helen L., et al.
Publicado: (2017)

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening
por: Ulph, Fiona, et al.
Publicado: (2015)

Hypersensitivity to parenteral antibiotics in patients with cystic fibrosis
por: Roehmel, Jobst, et al.
Publicado: (2014)

Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis
por: Gabrielaite, Migle, et al.
Publicado: (2021)

Rescue therapy within the UK Cystic Fibrosis Registry: An exploration of predictors of intravenous antibiotic use amongst adults with CF
por: Hoo, Zhe Hui, et al.
Publicado: (2017)

Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study
por: Barr, Helen L., et al.
Publicado: (2017)

Dynamics of soluble and cellular inflammatory markers in nasal lavage obtained from Cystic Fibrosis patients during intravenous antibiotic treatment
por: Hentschel, Julia, et al.
Publicado: (2014)

EPS1.02 The impact of COVID-19 on the prescribing practice of specialist cystic fibrosis physiotherapist non-medical prescribers in the UK
por: Brown, C., et al.
Publicado: (2021)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities
por: Nichols, Dave P., et al.
Publicado: (2019)

Use of inhaled antibiotics among Danish patients with cystic fibrosis
por: Møller, Rikke, et al.
Publicado: (2022)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future
por: Perikleous, Evanthia P., et al.
Publicado: (2023)

Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis
por: Webb, Karmel, et al.
Publicado: (2022)

Detection of Bacteriophage Particles Containing Antibiotic Resistance Genes in the Sputum of Cystic Fibrosis Patients
por: Brown-Jaque, Maryury, et al.
Publicado: (2018)

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
por: Taccetti, Giovanni, et al.
Publicado: (2021)

The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects
por: Van den Bossche, Sara, et al.
Publicado: (2021)

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosis
por: Kadeřábková, Nikol, et al.
Publicado: (2023)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Janahi, Ibrahim Ahmed, et al.
Publicado: (2017)

Mindfulness moderates the relationship between emotional eating and body mass index in a sample of people with cystic fibrosis
por: Egan, Helen, et al.
Publicado: (2020)

Do children with cystic fibrosis receiving outreach care have poorer clinical outcomes than those treated at a specialist cystic fibrosis centre?
por: Weber, Heinrich C., et al.
Publicado: (2016)

Novel reaction to new cystic fibrosis medication Trikafta
por: Stashower, Julian, et al.
Publicado: (2021)

Preferences for Prenatal Tests for Cystic Fibrosis: A Discrete Choice Experiment to Compare the Views of Adult Patients, Carriers of Cystic Fibrosis and Health Professionals
por: Hill, Melissa, et al.
Publicado: (2014)

Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
por: Papayannopoulos, Venizelos, et al.
Publicado: (2011)

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy
por: Westhölter, Dirk, et al.
Publicado: (2023)

Experiences and perceptions of receiving and prescribing rehabilitation in adults with cystic fibrosis undergoing lung transplantation
por: Wickerson, Lisa, et al.
Publicado: (2023)

250 Dosing and therapeutic drug monitoring of intravenous vancomycin in cystic fibrosis: A practice survey
por: Dagenais, R., et al.
Publicado: (2022)

Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor
por: Balmpouzis, Zisis, et al.
Publicado: (2022)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cannot write session to /tmp/vufind_sessions/sess_ehskvthdksglfesg4ua7s9etsq